Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer. Duro-Sanchez S, Nadal-Serrano M, Lalinde-Gutierrez M, Arenas EJ, et al. Cancer Res 2022 Oct 12. pii: 709715. doi: 10.1158/0008-5472.CAN-22-0787.

Read + Share

Amedeo Smart

Independent Medical Education

Duro-Sanchez S, Nadal-Serrano M, Lalinde-Gutierrez M, Arenas EJ, et al. Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer. Cancer Res 2022 Oct 12. pii: 709715. doi: 10.1158/0008-5472.CAN-22-0787.
PMID: 36222720